The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Fujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C., & Orkin, S. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12355 · Cited by 778
Tsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
Self-citationDiversification of haematopoietic stem cells to specific lineages
Orkin, S. H. (2000) · Nature Reviews Genetics · doi:10.1038/35049577 · Cited by 565
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
Nichols, K. E., Crispino, J. D., Poncz, M., White, J. G., Orkin, S. H., Maris, J. M., & Weiss, M. J. (2000) · Nature Genetics · doi:10.1038/73480 · Cited by 515
Self-citationTranscriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1.
Martin, D. I., & Orkin, S. H. (1990) · Genes & Development · doi:10.1101/gad.4.11.1886 · Cited by 409
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets
Vyas, P., Ault, K., Jackson, C. W., Orkin, S. H., & Shivdasani, R. A. (1999) · Blood · doi:10.1182/blood.v93.9.2867.409k24_2867_2875 · Cited by 362
Cited by
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570
Pushing the limits of the scanning mechanism for initiation of translation
Kozak, M. (2002) · Gene · doi:10.1016/s0378-1119(02)01056-9 · Cited by 919
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
Transcription factors in myeloid development: balancing differentiation with transformation
Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606
Creutzig, U., van den Heuvel-Eibrink, M. M., Gibson, B., Dworzak, M. N., Adachi, S., de Bont, E., Harbott, J., Hasle, H., Johnston, D., Kinoshita, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-362608 · Cited by 577
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506
GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis
Ferreira, R., Ohneda, K., Yamamoto, M., & Philipsen, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1215-1227.2005 · Cited by 442
Global regulation of erythroid gene expression by transcription factor GATA-1
Welch, J. J. (2004) · Blood · doi:10.1182/blood-2004-04-1603 · Cited by 411
The landscape of somatic mutations in Down syndrome–related myeloid disorders
Yoshida, K., Toki, T., Okuno, Y., Kanezaki, R., Shiraishi, Y., Sato-Otsubo, A., Sanada, M., Park, M.-J., Terui, K., Suzuki, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2759 · Cited by 382
“Down syndrome: an insight of the disease”
Asim, A., Kumar, A., Muthuswamy, S., Jain, S., & Agarwal, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0138-y · Cited by 371
Discovering Hematopoietic Mechanisms through Genome-wide Analysis of GATA Factor Chromatin Occupancy
Fujiwara, T., O'Geen, H., Keles, S., Blahnik, K., Linnemann, A. K., Kang, Y.-A., Choi, K., Farnham, P. J., & Bresnick, E. H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.001 · Cited by 350
Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia
Sankaran, V. G., Ghazvinian, R., Do, R., Thiru, P., Vergilio, J.-A., Beggs, A. H., Sieff, C. A., Orkin, S. H., Nathan, D. G., Lander, E. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63597 · Cited by 342
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
Elagib, K. E., Racke, F. K., Mogass, M., Khetawat, R., Delehanty, L. L., & Goldfarb, A. N. (2003) · Blood · doi:10.1182/blood-2002-09-2708 · Cited by 332
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61341-0 · Cited by 337
The aurora kinases in cell cycle and leukemia
Goldenson, B., & Crispino, J. D. (2015) · Oncogene · doi:10.1038/onc.2014.14 · Cited by 334
Self-citationGATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome
Hitzler, J. K., Cheung, J., Li, Y., Scherer, S. W., & Zipursky, A. (2003) · Blood · doi:10.1182/blood-2003-01-0013 · Cited by 326
Activating alleles of JAK3 in acute megakaryoblastic leukemia
Walters, D. K., Mercher, T., Gu, T.-L., O'Hare, T., Tyner, J. W., Loriaux, M., Goss, V. L., Lee, K. A., Eide, C. A., Wong, M. J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.002 · Cited by 317
Self-citationMassey, G. V., Zipursky, A., Chang, M. N., Doyle, J. J., Nasim, S., Taub, J. W., Ravindranath, Y., Dahl, G., & Weinstein, H. J. (2006) · Blood · doi:10.1182/blood-2005-06-2448 · Cited by 312
Developmental stage–selective effect of somatically mutated leukemogenic transcription factor GATA1
Li, Z., Godinho, F. J., Klusmann, J.-H., Garriga-Canut, M., Yu, C., & Orkin, S. H. (2005) · Nature Genetics · doi:10.1038/ng1566 · Cited by 305
Altered translation of GATA1 in Diamond-Blackfan anemia
Ludwig, L. S., Gazda, H. T., Eng, J. C., Eichhorn, S. W., Thiru, P., Ghazvinian, R., George, T. I., Gotlib, J. R., Beggs, A. H., Sieff, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3557 · Cited by 302
Rainis, L. (2003) · Blood · doi:10.1182/blood-2002-11-3599 · Cited by 291
GATA Transcription Factors and Cancer
Zheng, R., & Blobel, G. A. (2010) · Genes & Cancer · doi:10.1177/1947601911404223 · Cited by 276
Mutation of GATA3 in human breast tumors
Usary, J., Llaca, V., Karaca, G., Presswala, S., Karaca, M., He, X., Langerød, A., Kåresen, R., Oh, D. S., Dressler, L. G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207966 · Cited by 277
GATA Switches as Developmental Drivers
Bresnick, E. H., Lee, H.-Y., Fujiwara, T., Johnson, K. D., & Keles, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.159079 · Cited by 269
Loughran, S. J., Kruse, E. A., Hacking, D. F., de Graaf, C. A., Hyland, C. D., Willson, T. A., Henley, K. J., Ellis, S., Voss, A. K., Metcalf, D., et al. (2008) · Nature Immunology · doi:10.1038/ni.1617 · Cited by 269
Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
Klusmann, J.-H., Creutzig, U., Zimmermann, M., Dworzak, M., Jorch, N., Langebrake, C., Pekrun, A., Macakova-Reinhardt, K., & Reinhardt, D. (2008) · Blood · doi:10.1182/blood-2007-10-118810 · Cited by 258
FOG‐1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA‐1
Hong, W., Nakazawa, M., Chen, Y., Kori, R., Vakoc, C. R., Rakowski, C., & Blobel, G. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600703 · Cited by 253
Trisomy 21 and early brain development
Haydar, T. F., & Reeves, R. H. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.001 · Cited by 200
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184
Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.
Waltzer, L., Ferjoux, G., Bataille, L., & Haenlin, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg622 · Cited by 129
Porse, B. T., Bryder, D., Theilgaard-Mönch, K., Hasemann, M. S., Anderson, K., Damgaard, I., Jacobsen, S. E. W., & Nerlov, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050067 · Cited by 117
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
Shaham, L., Vendramini, E., Ge, Y., Goren, Y., Birger, Y., Tijssen, M. R., McNulty, M., Geron, I., Schwartzman, O., Goldberg, L., et al. (2015) · Blood · doi:10.1182/blood-2014-06-581892 · Cited by 74
Self-citationRole of Transcription Factors C/EBPa and PU.1 in Normal Hematopoiesis and Leukemia
Koschmieder, S., Rosenbauer, F., Steidl, U., Owens, B. M., & Tenen, D. G. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05051 · Cited by 72
Gain‐of‐Function Effects of N‐Terminal CEBPA Mutations in Acute Myeloid Leukemia
Schmidt, L., Heyes, E., & Grebien, F. (2020) · BioEssays · doi:10.1002/bies.201900178 · Cited by 26
Metadata
- Authors
- Wechsler, J., Greene, M., McDevitt, M. A., Anastasi, J., Karp, J. E., Le Beau, M. M., & Crispino, J. D.
- Venue
- Nature Genetics
- Published
- 2002-08-12
- Volume
- 32
- Issue
- 1
- Pages
- 148-152
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1976386009
- Cited by
- 760
- References
- 27
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.